Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer. J Clin Oncol 1995; 13: 1860–70Langer CJ, Leighton J, McAleer C, et al: Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer. Semin Oncol 22:64-69, 1995...
(FDA MedWatch definition) when the patient outcome is: death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent impairment or damage Sixteen women aged 39-81 years developed haematological toxicity during treatment with carboplatin and paclitaxel for ...
Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a Phase II trial. Br J Cancer 1998;78:370 - 4.Zielinski CC, Schnack B, Grbovic M, Brodowicz T, Wiltschke C, Steger G, et al. Paclitaxel and carboplatin in patients with metastatic urothelial cancer: ...
It stops or slows the growth of cancer cells and other fast-growing cells by destroying their DNA. It is usually given as an injection and may be taken alone or together with other chemotherapy as first-line treatment. For example, Carboplatin and Paclitaxel. Indications of Carboplatin and ...
aErlotinib with concurrent carboplatin and paclitaxel did not confer a survival advantage over carboplatin and paclitaxel alone in patients with previously untreated advanced NSCLC Erlotinib与一致carboplatin和paclitaxel没有商谈单独生存好处结束carboplatin和paclitaxel在患者与早先未经治疗的先进的NSCLC[translate]...
The article discusses research being done on the efficacy of using paclitaxel plus carboplatin, and docetaxel alone for treating patients with advanced or recurrent endometrial cancer. It references studies by T. Arimoto et al and A. R. G眉nthert et al, both published in the January 2007 ...
Combination of paclitaxel and carboplatin as second‐line therapy for patients with metastatic melanomaData previously presented at the annual meeting of the American Society of Clinical Oncology, Orlando, Florida, May 13–17, 2005.Institutional review b Cancer (0008543X)Ravi D. RaoShernan G. ...
Paclitaxel and carboplatin are high utility rates in the clinical anticancer drug, often compatibility in clinical use to treat various cancers. 翻译结果2复制译文编辑译文朗读译文返回顶部 正在翻译,请等待... 翻译结果3复制译文编辑译文朗读译文返回顶部 ...
Paclitaxel (Taxol; Bristol-Myers Squibb Oncology, Princeton, NJ) and carboplatin have each shown activity against non-small cell lung cancer and they are synergistic in vitro. We thus designed a phase I study to define the maximum tolerated dose and dose-limiting toxicity of the combination with...
when the patient outcome is: death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent impairment or damage A 60-year-old woman developed peripheral arterial thrombosis during postoperative chemotherapy with carboplatin and paclitaxel for ovarian and endometrial...